BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1380 related articles for article (PubMed ID: 14974925)

  • 1. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of salivary cortisol in Cushing's syndrome (CS).
    Cardoso EM; Arregger AL; Tumilasci OR; Contreras LN
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):516-21. PubMed ID: 18710466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Jung C; Alford FP; Topliss DJ; Burgess JR; Long F; Gome JJ; Stockigt JR; Inder WJ
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):78-84. PubMed ID: 20039897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of salivary cortisol in Cushing's syndrome].
    Shi SR; Gan W; Zhou XT; Xiong ZY; An ZM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):298-301. PubMed ID: 19462912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test.
    Nickelsen T; Lissner W; Schöffling K
    Exp Clin Endocrinol; 1989; 94(3):275-80. PubMed ID: 2560985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.
    Dias R; Storr HL; Perry LA; Isidori AM; Grossman AB; Savage MO
    Horm Res; 2006; 65(3):159-62. PubMed ID: 16514243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
    Gatta B; Chabre O; Cortet C; Martinie M; Corcuff JB; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
    Contreras LN; Arregger AL; Persi GG; Gonzalez NS; Cardoso EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
    Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
    Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of CRF-41 in the differential diagnosis of Cushing's syndrome and obesity.
    Grossman A; Howlett TA; Kopelman PG
    Horm Metab Res Suppl; 1987; 16():62-4. PubMed ID: 2832293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
    Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
    Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.